GlassScriptPhysician profile
Anupama Rao
NPI 1255399481
$4,210.45
in general payments reported to CMS, 2019-2025
20 companies · $1,979 in 2025
The $1,979 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $585 · 2021: $357 · 2022: $155 · 2023: $342 · 2024: $208 · 2025: $1,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,400 · Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,400.00 |
| Food and Beverage | $1,128.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,537.06 | 2019-2023 | Verquvo |
| Bridgebio Pharma, INC. | $1,503.52 | 2025 | Attruby |
| Amgen INC. | $303.09 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $166.58 | 2022-2025 | |
| Heartflow, INC. | $164.34 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $79.88 | 2023-2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.63 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $42.46 | 2022-2024 | Xarelto |
| Philips North America LLC | $42.16 | 2025 | Epiq Cvx, Ambulatory Monitoring & Diagnostics Undivided |
| E.R. Squibb & Sons, L.L.C. | $40.59 | 2023-2024 | Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $40.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $40.01 | 2024 | |
| Medtronic, INC. | $34.77 | 2023 | Harmony |
| Lantheus Medical Imaging, INC. | $27.04 | 2024 | |
| Abbott Laboratories | $24.07 | 2023 | Confirm Rx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $22.32 | 2021 | |
| Zoll Circulation INC | $20.47 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Astrazeneca Pharmaceuticals LP | $19.14 | 2023 | Farxiga |
| Siemens Medical Solutions USA, INC. | $17.27 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Bayer Healthcare Pharmaceuticals INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupama Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.